61 results
6-K
TAK
Takeda Pharmaceutical Co
16 Jan 24
Current report (foreign)
6:01am
supply model. This initiative aligns with the reinforced quality assurance system for pharmaceutical products in the industry. We are committed to ensuring … , warehousing, manufacturing support, and quality assurance)
(5) Capital amount
1,676,345 million yen
50 million yen
(6) Date of foundation / incorporation
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
with the laws and regulations of the pharmaceutical industry (GxP). The Company has established the Group Internal Audit (GIA), an independent assurance … and maintains an audit quality assurance and improvement program and conducts internal audit activities in accordance with the “International
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
of the pharmaceutical industry (GxP). The Company has established the Group Internal Audit (GIA), an independent assurance function within Takeda Group, to support … the enhancement and protection of organizational value through its audit activities. The GIA department develops and maintains an audit quality assurance
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
indicated, our corporate philosophy metrics have been assured by KPMG AZSA Sustainability Co., Ltd. (KPMG). Details on assurance methodology
6-K
EX-99.1
yay9zg 6x
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
q2fue
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
3zwyj2x0o g5
30 May 23
Current report (foreign)
6:11am
6-K
m9dibpxqmxn52 xj
4 Nov 22
Current report (foreign)
6:01am
6-K
8v6wpxv1kgl1pk4ppuf
4 Aug 22
Current report (foreign)
6:07am
6-K
915rh82 qtn
11 Jul 22
Current report (foreign)
6:05am
6-K
7pvfq6vra0q7zcgdww1
31 May 22
Current report (foreign)
6:20am
6-K
EX-99.1
v7fske jkuqtc9j
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
o4sq3va9
31 May 22
Current report (foreign)
12:00am